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Retinal	degeneration	causes	vision	impairment	and	blindness	in	humans.	If	one	day	we	are	to	harness	the	
potential	of	stem	cell–based	cell	replacement	therapies	to	treat	these	conditions,	it	is	imperative	that	we	better	
understand	normal	retina	development.	Currently,	the	genes	and	mechanisms	that	regulate	the	specification	
of	the	neuroretina	during	vertebrate	eye	development	remain	unknown.	Here,	we	identify	sine	oculis–related	
homeobox	3	(Six3)	as	a	crucial	player	in	this	process	in	mice.	In	Six3	conditional–mutant	mouse	embryos,	
specification	of	the	neuroretina	was	abrogated,	but	that	of	the	retinal	pigmented	epithelium	was	normal.	
Conditional	deletion	of	Six3	did	not	affect	the	initial	development	of	the	optic	vesicle	but	did	arrest	subse-
quent	neuroretina	specification.	Ectopic	rostral	expansion	of	Wnt8b	expression	was	the	major	response	to	Six3	
deletion	and	the	leading	cause	for	the	specific	lack	of	neuroretina,	as	ectopic	Wnt8b	expression	in	transgenic	
embryos	was	sufficient	to	suppress	neuroretina	specification.	Using	chromatin	immunoprecipitation	assays,	
we	identified	Six3-responsive	elements	in	the	Wnt8b	locus	and	demonstrated	that	Six3	directly	repressed	Wnt8b	
expression	in	vivo.	Our	findings	provide	a	molecular	framework	to	the	program	leading	to	neuroretina	differ-
entiation	and	may	be	relevant	for	the	development	of	novel	strategies	aimed	at	characterizing	and	eventually	
treating	different	abnormalities	in	eye	formation.
Introduction
Various human ocular diseases due to retinal degeneration lead 
to vision impairment and eventually blindness. Recent advances 
using embryonic stem cells and induced pluripotent stem cells 
suggest that one day cell-replacement therapy will be used to treat 
some of these diseases (1, 2). A prerequisite to achieving this goal 
is to better understand the regulatory cascade and signaling path-
ways that control normal retina development.
In vertebrates, the retina is composed of the neuroretina (NR) 
and the retina pigment epithelium (RPE), both derived from 
common progenitors located in the early eye field and its deriva-
tive, the optic vesicles (3). In the mouse, fate-mapping analysis of 
5- to 7-somite staged (i.e., E8.5) embryos places the eye field in the 
rostral anterior neural plate (4). As a result of coordinated inter-
actions of the neuroepithelium, overlying surface ectoderm, and 
mesenchyme, the eye field undergoes extensive morphogenesis to 
form the optic vesicles (E9.0–E9.5) and optic cup (E10.5). At E9.5, 
the optic vesicle and the overlying surface ectoderm are in close 
contact. At E10.5, the double-layered optic cups form, and the 
NR and RPE become morphologically distinguishable, i.e., NR 
progenitors are localized in the inner layer and RPE progenitors 
are in the outer layer. Eventually, NR progenitors give rise to the 
6 major types of differentiated neurons and 1 type of glial cell in 
the mature neuroretina (5).
Similar to the eye field of the frog (6, 7), that of the mouse 
expresses a series of characteristic transcription factors including 
Six3, Rax (also known as Rx), Lhx2, and Pax6 (8). Later, during the 
formation of the optic vesicles (E9.0–E9.5), additional genes are 
expressed, including Six6 in presumptive NR progenitors (9), Vax2 
in the ventral optic vesicles and optic stalk (10), Tbx5 in the dorsal 
optic vesicles (11), and the bHLH leucine–zipper transcription fac-
tor Mitf in the whole optic vesicle (12). At around E10.5, nascent 
NR progenitors are marked by the onset of Vsx2 (also known as 
Chx10) expression, and the RPE progenitors are marked by the 
restricted expression of Mitf (12).
In the mouse, some key genes responsible for eye development 
have been identified. For example, formation of the eye field and 
optic vesicles requires the activity of Lhx2 and Rax (8, 13–16). Func-
tional inactivation of Pax6 affects the formation of the optic cup; 
however, NR specification is normal, as indicated by the expression 
of the NR progenitor marker Vsx2 (17). In contrast to the crucial role 
of Fzd5 in zebrafish eye development, functional inactivation of Fzd5 
in mice causes defects only in the invagination of the optic vesicles; 
NR specification is not affected (18). Functional inactivation of Six6 
(19), Vax2 (10), Vsx2 (20, 21), or Mitf (22) causes some later defects in 
eye development but does not affect NR specification.
Despite this progress, the molecular mechanisms controlling the 
key step of NR specification during vertebrate eye development 
remain largely unknown.
The homeobox gene Six3 has a dynamic expression profile dur-
ing early forebrain and eye development (23), and previous work 
has determined that Six3 activity is essential for forebrain forma-
tion (24). In this paper, we show that conditional removal of Six3 
from the developing mouse eye field is sufficient to arrest NR 
specification. In the generated Six3 conditional mutant embryos, 
eye field induction was not affected; however, NR specification 
did not take place in the mutant optic vesicles, but RPE specifica-
tion appeared normal. Therefore, this is the first animal model 
in which NR specification is specifically arrested. We provide evi-
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dence that Six3-mediated direct suppression of Wnt8b is a required 
step for NR specification in mammals and that a tightly regulated 
temporal and spatial balance of Wnt/β-catenin signaling is essential 
for telencephalon, NR, and RPE specification.
Results
Six3 conditional–mutant embryos lack the NR but exhibit a normal RPE. 
To address the role of Six3 in NR development, we generated Six3F/Δ; 
Rx-Cre mutant embryos (referred to as Six3Rx-Cre-KO hereafter) by 
crossing the floxed Six3 mouse strain (25) with the Rx-Cre strain 
(26). Activity of Rx-Cre was associated with retina-forming cells 
located in the anterior neural plate and eye field at around E8.5 
(Supplemental Figure 1; supplemental material available online 
with this article; doi:10.1172/JCI43219DS1) (26). Initial mor-
phologic analysis of Six3 conditional–mutant embryos at E11.5 
revealed that most exhibited a relatively normal-looking brain, 
though the brain was reduced in size in some embryos. The eyes 
of these embryos also appeared smaller and composed exclusively 
of pigmented cells (Figure 1, B and C). A low percentage of the iso-
lated mutant embryos lacked a forebrain, a phenotype similar to 
that previously reported for the standard Six3-null embryos (24).
Next we performed a detailed characterization of conditional-
mutant embryos at E10.5, a stage when the NR and RPE are eas-
ily distinguished by the use of molecular markers. This analysis 
revealed the presence of a mutant optic cup devoid of Six3 expres-
sion (Figure 1E). Other typical NR markers such as Rax, Sox2, 
and Vsx2 were also missing (Figure 1, G, I, and K). In contrast, the 
entire mutant optic vesicle expressed the RPE-specific marker Mitf 
(Figure 1M) as well as Pax6, a gene that at this stage is normally 
expressed by both the NR and RPE (Figure 1, N and O).
Together, these results identified Six3 as a gene whose activity is 
required for the development of the mammalian NR but not for 
the formation of the RPE.
NR specification is arrested in Six3Rx-Cre-KO embryos. To pinpoint the 
developmental phase when phenotypic alterations arise, we per-
formed a molecular characterization of the mutant embryos at the 
optic vesicle stage (E9.0–E9.5).
The frizzled family member Fzd5 is expressed in the eye field, 
developing optic cups, and retina, and in frogs, its activity is required 
to promote the neural fate of retinal progenitors (18, 27–30). 
Unlike that in frogs, Fzd5 activity in mammals is required for optic 
cup morphogenesis but not for NR specification (18). Strong Fzd5 
expression was detected in the anterior part of the ventral fore-
brain and optic vesicles of E9.0 control embryos (Figure 2A); in 
contrast, it was absent in Six3Rx-Cre-KO littermates (Figure 2B).
The homeobox-containing gene Rax is required for the forma-
tion of the optic vesicles and all of its derivatives in vertebrate 
embryos (14, 30). At the 15-somite stage, Rax expression was local-
Figure 1
Six3 activity is crucial for the 
development of the mammalian 
neuroretina. (A) At E11.5, a nor-
mal-looking pigmented eye is 
seen in control embryos. In Six3 
conditional–mutant littermates, 
the eye appears defective and 
composed of only the RPE (B 
and C). At E10.5, NR specifica-
tion has already taken place in 
control embryos, as indicated by 
the expression of the NR mark-
ers Six3 (D), Rax (F), Sox2 (H), 
and Vsx2 (J). In the conditional-
mutant littermates, this process 
is defective, as revealed by the 
lack of expression of any of 
these NR markers (arrows in 
E, G, I and K). At this stage, the 
RPE is also normally detected, 
as indicated by the expression 
of Mitf (L) and Pax6 (N). In Six3 
conditional–mutant embryos, 
the expression of these 2 tran-
scription factors highlights the 
fact that the mutant optic ves-
icle is exclusively composed 
of the RPE (arrows in M and 
O). Scale bars: 500 μm (A–C); 
100 μm (D–O).
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ized in the developing optic vesicles (Figure 2C); however, in the 
mutant embryos its expression was missing in the most dorsal part 
of the optic vesicles (Figure 2D) and was abnormally present in the 
midline region of the forebrain (Figure 2D).
A Six3-related family member, Six6, is expressed in the presumptive 
ventral optic stalk, the ventral portion of the future NR, and later in 
the NR, optic chiasm, and optic stalk (9). Six6-null embryos exhibit 
variable degrees of retinal hypoplasia associated with the absence of 
the optic chiasm and optic nerve (19). We detected strong expression 
of Six6 in the optic vesicles and midline part of the ventral forebrain in 
E9.0 control embryos (Figure 2, E and G). This expression was unde-
tectable in Six3 conditional–mutant littermates (Figure 2, F and H).
Similarly, the expression of the presumptive ventral NR marker 
Vax2 (10) and that of the presumptive dorsal NR marker Tbx5 (11) 
was also missing in the mutant embryos (Figure 2, I–L). Instead, 
at this stage, expression of the presumptive RPE marker Mitf (12) 
remained in the mutant optic vesicles (Figure 2, M–P).
The transcription factor Sox2 is expressed in neural and placodal 
primordia at E8.5 (31), and its activity is required to regulate the 
competence of NR progenitors; 10% of humans with anophthalmia 
or severe microphthalmia are haploid insufficient for Sox2 (32). We 
observed no obvious changes in the expression of Sox2 in the ante-
rior neural region, including the optic vesicle territory, in Six3 con-
ditional–mutant embryos (Supplemental Figure 2).
Together, these results argue that the conditional deletion of 
Six3 has no major consequences on the initial process of optic 
vesicle formation; instead, it arrested the subsequent process of 
NR specification, as indicated by the lack of expression of some 
important players in the mutant optic vesicles as early as E9.0.
To determine whether the observed defects were caused by 
alterations in cell proliferation or cell death, we performed 
pH3 immunostaining, TUNEL assays, and activated caspase-3 
immunostaining in E8.5–E9.0 embryos. No significant difference 
was observed in the number of pH3-positive cells (P = 0.525, t test) 
Figure 2
Expression of typical optic vesicle markers is missing or defective in Six3 conditional–mutant embryos. (A) At the 13-somite stage, Fzd5 expres-
sion is normally seen in the optic vesicles (arrow) and ventral forebrain of control embryos. (B) This expression was absent in the Six3-mutant lit-
termates. (C) At the 15-somite stage, normal Rax expression is seen in the optic vesicles (arrow). (D) In the mutant littermates, Rax expression is 
missing from the dorsal optic vesicles and does not separate properly in the ventral midline region of the forebrain (arrowhead). (E and G) At this 
same stage, Six6 expression is seen in presumptive NR progenitors in the optic vesicles (arrows) and ventral forebrain (arrowhead). (F and H) 
In Six3 conditional–mutant littermates, Six6 expression was almost completely absent from those territories (arrow and arrowhead). At the 
21-somite stage, expression of the ventral (Vax2; I and J) and dorsal (Tbx5; K and L) optic vesicle markers was also undetectable in Six3-mutant 
embryos. (M–P) At this stage, expression of Mitf remained in the mutant optic vesicles. Scale bar: 100 μm.
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between control embryos (13.2% ± 1.5%) and Six3 conditional–
mutant embryos (11.3% ± 2.0%). (Supplemental Figure 3, C and 
D). At this stage, TUNEL+ cells or activated caspase-3+ cells were 
observed in the ventral part of the optic vesicles of control embry-
os (Supplemental Figure 3, E and G); these cells were absent in the 
Six3-deficient littermates (Supplemental Figure 3, F and H), and 
no ectopic apoptosis was observed. Only at later stages (16-somite 
stage) did we observe some limited ectopic apoptosis toward the 
dorsal part of the mutant optic vesicles of Six3-deficient embryos 
(Supplemental Figure 3J). Thus, it is unlikely that drastic altera-
tions in proliferation or apoptosis are responsible for the NR 
defects observed in early stage Six3-mutant embryos.
Eye field is induced in Six3 conditional–mutant embryos. Six3 is nor-
mally expressed in the mouse eye field territory, the region of the 
anterior neural plate from which the eyes eventually form at E8.5 
(23). Analysis of X-gal–stained Rx-Cre;R26R embryos identified the 
presence of Rx-Cre+ cells in the anterior neural plate territory at 
E7.5 (Supplemental Figure 1). As development progresses, X-gal+ 
cells were also observed in the eye field territory and developing 
optic vesicles (Supplemental Figure 1).
To determine whether the lack of NR observed in Six3Rx-Cre-KO 
embryos could be the consequence of early defects in eye field spec-
ification or formation, we analyzed the expression of Six3 and that 
of the eye field markers Rax (14) and Lhx2 (8) at E8.5. Six3 started 
to be deleted in a mosaic manner as early as the 6-somite stage 
(Figure 3B). However, expression of the eye field markers Rax (14) 
and Lhx2 (8) was largely unaffected (Figure 3, D and F). Mosaic 
deletion of Six3 was also evident at the 9-somite stage; however, 
at that stage, a more efficient deletion was observed toward the 
rostral margin of the neural ridge (Figure 3, H and J).
In summary, deletion of Six3 from the anterior neural plate and 
eye field of Six3Rx-Cre-KO embryos did not obviously affect the process 
of eye field induction. Importantly, this early mosaic deletion was 
sufficient to alter the levels of Six3 expression in the rostral margin 
of the anterior neural ridge and the region of the optic evaginations 
at the 9-somite stage (Figure 3, G–J). Furthermore, we observed 
some of the first obvious morphologic defects at this stage in the 
optic vesicles territory that failed to evaginate properly (Figure 3J).
Rostral expansion of Wnt8b/β-catenin signaling is an early response to 
Six3 deletion. As indicated above, the earliest alterations in Six3Rx-Cre-KO 
embryos were detected at around the 6- to 9-somite stage, when 
Six3 expression in the eye field territory and anterior neural ridge 
was reduced. Therefore, to gain insight into the molecular mecha-
nisms that lead to the subsequent NR specification defects, we per-
formed microarray analysis of dissected anterior neural plate ter-
ritory from 8- to 9-somite staged Six3Rx-Cre-KO embryos and control 
littermates. Among the genes that exhibited significant expression 
change were several components of the Wnt signaling pathway 
including Wnt8b (data not shown).
Work performed in zebrafish has suggested that Wnt/β-catenin 
signaling antagonizes eye field specification through the activity of 
wnt8b and Fz8a (27). In mouse embryos at the 8-somite stage (eye 
field stage), Wnt8b expression was localized in the dorsal midline of the 
caudal forebrain (Figure 4, A and C), at the boundary with the mid-
Figure 3
Eye field is induced in Six3Rx-Cre-KO embryos. Expression of typical eye field markers such as Six3 (A), Rax (C), and Lhx2 (E) can be detected by 
whole-mount in situ hybridization analysis of 6-somite staged wild-type embryos. Although reduced, the expression of these markers persists in 
the eye field territory of Six3 conditional–mutant littermates (B, D, and F). At the 9-somite stage, Six3 expression includes the evaginating optic 
vesicles (G and I). In conditional-mutant littermates, Six3 expression was reduced in a mosaic manner in most of that region (arrows in J) and 
in the rostral margin expression was almost completely absent (arrowheads in H and J). Scale bar: 100 μm.
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brain (33), and did not overlap with that of Six3, which was located in 
the anterior neural plate at this stage (23). Instead, in Six3 condition-
al–mutant embryos and starting at around this stage, Wnt8b expres-
sion was ectopically expanded into the anterior-most part of the fore-
brain including the optic pits (Figure 4, B, D, and M). Consistent with 
this ectopic expansion of Wnt8b, expression of Axin2, an endogenous 
readout of Wnt/β-catenin signaling (34), was also anteriorly expanded 
in the mutant embryos (Figure 4, G, H, and N). Confirming this result 
further, we found that the activity of the Wnt/β-catenin reporter (35) 
was also rostrally expanded at this stage (Figure 4, I, J, O, and P). This 
ectopic anterior expansion of the Wnt8b expression domain was main-
tained during later developmental stages (Figure 4, E and F).
We previously reported that the standard functional inactiva-
tion of Six3 leads to the rostral expansion of Wnt1 expression and 
truncation of the mutant prosencephalon (24). Interestingly, in 
Six3Rx-Cre-KO embryos, Wnt8b expression expanded rostrally but 
that of Wnt1 was normal (Figure 4, K and L). In fish, Wnt11, Fz5, 
Fz8a, and Sfrp1, in addition to Wnt8b, are also involved in early eye 
development (27, 36–38). In Six3Rx-Cre-KO embryos, Fzd5 expression 
was significantly reduced in the anterior neural plate at the 6- to 
8-somite stage (data not shown), but that of Sfrp1 and Fzd8 was 
unaffected, and Wnt11 was not expressed in the anterior neural 
plate of control or mutant embryos (data not shown).
Together, these results indicated that functional inactivation of 
Six3 in the anterior neural plate (including the eye field territory) 
led to the specific rostral expansion of Wnt8b expression starting 
as early as E8.5.
Ectopic Wnt8b expression is sufficient to suppress NR specification in trans-
genic mouse embryos. Considering that the observed rostral expansion 
of Wnt8b expression is an early response to Six3 deficiency and that in 
zebrafish wnt8b antagonizes eye field specification (27), we decided to 
determine whether ectopic Wnt8b expansion is responsible for the lack 
of NR specification observed in Six3 conditional–mutant embryos.
To do this, we generated transient transgenic mouse embryos 
in which ectopic Wnt8b expression was driven into the anterior 
forebrain territory by a Fezf2 promoter/regulatory element (39). In 
Figure 4
Wnt8b but not Wnt1 expression is rostrally expanded in Six3Rx-Cre-KO embryos at E8.5. (A and C) Whole-mount in situ hybridization of 8-somite 
staged control embryos shows that at this stage, Wnt8b expression is localized at the boundary between the caudal forebrain and midbrain, 
and its anterior-most boundary (arrowheads) clearly excludes the eye field territory. Wnt8b expression expanded anteriorly (arrowheads in B 
and D) into the developing telencephalon and eye field territory of Six3 conditional–mutant littermates. This ectopic expansion remains in later-
staged mutant embryos (E and F). Accordingly, expression of the Wnt/β-catenin signaling readouts, Axin2 (G and H), and the BAT-gal reporter 
(I and J), were also anteriorly expanded (arrowheads). The expression of Wnt1 was unaffected in Six3-mutant embryos (arrowheads in K and 
L). Transverse sections at the level of the optic pit indicated by the dash in the embryos shown in D, H, I, and J are shown in M, N, O, and P, 
respectively. Scale bar: 100 μm.
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this construct, ectopic transgene expression can be monitored by 
yellow fluorescent protein (YFP) fluorescence. Although variable, 
in some of the transgenic embryos, YFP was detected in the fore-
brain territory as early as the 8- to 11-somite stage (E8.5; Figure 5, 
A and B) and remained at least until the E10.5 stage (Figure 5, C 
and D). Analysis of the transgenic embryos at E10.5 revealed that 
similar to Six3Rx-Cre-KO embryos, expression of the NR markers Six3, 
Rax, Sox2, and Vsx2 was missing or drastically reduced (Figure 5, 
E–L); in contrast, the entire optic vesicle expressed the RPE-spe-
cific marker Mitf (Figure 5P) and Pax6, a gene that at this stage is 
expressed in the NR and RPE (Figure 5, M and N).
In summary, these results demonstrated that ectopic expression 
of Wnt8b in the early mouse forebrain was sufficient to arrest NR 
specification and recapitulated the phenotype observed in Six3 
conditional–deficient embryos at E10.5.
Six3 is an in vivo transcriptional regulator of Wnt8b. One possible 
explanation for the ectopic anterior expansion of Wnt8b is that 
Six3 activity directly maintains a Wnt8b-free territory at the time 
and in the region where NR specification normally occurs. There-
fore, to determine whether Six3 acts as a direct in vivo repressor 
of Wnt8b, we performed a detailed bioinformatic analysis of the 
Wnt8b genomic locus. We identified 2 highly conserved noncoding 
regions among human, chicken, zebrafish, and fugu fish: 1 region 
corresponded to the promoter region, and the other was located 
in the 3′ flanking region (Figure 6A). Visual examination of these 
2 regions also revealed several Six3 DNA–binding motifs (ref. 40 
and Supplemental Figure 4).
To determine whether Six3 functions as an in vivo regulator 
of Wnt8b activity, we first performed EMSA that showed that 
Six3 specifically binds the 2 conserved DNA fragments pres-
ent in the Wnt8b locus in vitro (Figure 6B). We also determined 
that forced expression of Six3 in the presumptive forebrain ter-
ritory of transgenic mouse embryos (driven by the same Fezf2 
promoter/regulatory element; ref. 39 described above) drastically 
reduced Wnt8b expression in this region (Figure 6, C–E). Finally, 
ChIP analysis of chromatin isolated from the head and trunk of 
E8.5 embryos by using a rabbit polyclonal antibody specific for 
Six3 or normal rabbit IgG was performed and specific regions of 
the immunoprecipitated chromatin were quantified by quantita-
tive PCR (qPCR). Enrichment was measured as the ratio between 
Figure 5
Ectopic Wnt8b expression in transient transgenic mouse embryos recapitulates the retinal phenotype of Six3-deficient embryos. Ectopic Wnt8b 
expression was driven by a Fezf2 promoter/regulatory element, and transient transgenic embryos were analyzed at E10.5. (A–D) Transgene 
expression in the forebrain and optic vesicles can be monitored by YFP immunofluorescence starting at the 8- to 11-somite stage. At around E10.5, 
NR progenitors express Six3 (E), Rax (G), Sox2 (I), and Vsx2 (K). Similarly to Six3 conditional mutants, transgenic embryos ectopically expressing 
Wnt8b in the rostral forebrain fail to express any of these NR markers (arrows in F, H, J, and L). In contrast to control embryos (M and O) and also 
similar to Six3 conditional–mutant embryos, the entire transgenic optic vesicle expresses Pax6 (N) and Mitf (P). Scale bars: 100 μm.
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Six3 immunoprecipitated chromatin and the corresponding IgG 
immunoprecipitated chromatin. Using this approach, we detect-
ed an 8.1-fold enrichment of the promoter region and a 3.7-fold 
enrichment of the 3′ flanking region (Figure 6F).
Together these results argue that Six3 directly suppresses 
Wnt8b expression in vivo in the anterior neural plate territory of 
early mouse embryos.
Discussion
In vertebrates, eye formation starts with the regionalization and 
specification of the eye field in the anterior neural plate. Within this 
region, retinal specification is initiated upon the formation of the 
optic sulci, the 2 lateral grooves of the anterior neuroectoderm from 
which the optic vesicles eventually evaginate. The transcription fac-
tors Rax, Six3, Six6, Lhx2, and Pax6 regulate eye development and are 
Figure 6
Six3 binds to Wnt8b regulatory elements in vivo. (A) DNA sequence comparison of the Wnt8b genomic loci of mouse, human, zebrafish, chick, 
and fugu fish revealed 2 conserved regions located outside the exons: the promoter and a 3′ flanking fragment. (B) DNA fragments containing 
potential Six3-binding motifs for both areas were subjected to EMSA analysis. Addition of GST-Six3 protein caused a band shift of the radiola-
beled probes, and addition of the Six3 antibody supershifted (red rectangle) those bands. Cold probes (in ×400 excess) were used to compete 
with the band shift. (C–E) Forced Six3 expression in the presumptive forebrain territory of E8.5 mouse embryos repressed Wnt8b expression. 
The anterior boundaries of Wnt8b expression in control (C) and in the transgenic embryo (D) are indicated by arrowheads. Expression of the 
transgene is monitored by YFP fluorescence (E). (F) Chromatin prepared from the head (Six3 positive) or trunk (Six3 negative) of 8- to 15-somite 
staged wild-type embryos was used for ChIP using either Six3 antibody or normal rabbit IgG and quantified by SYBR qPCR. The y axis indicates 
the value ratio between the Six3 and the corresponding IgG immunoprecipitated samples. Six3 was highly enriched in the promoter area and 
moderately enriched in the 3′ flanking area. (G) Working model of NR specification. Normally, the eye field (EF) territory will be derived from the 
anterior neural plate (ANP). Later on, the NR and RPE will be derived from this region, but while RPE specification requires active Wnt/β-catenin 
signaling, the specification of the NR fate requires its repression by Six3. Scale bar: 100 μm.
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coexpressed during most of the steps leading to NR differentiation 
(7, 9, 14, 19, 23). Gain-of-function approaches to increase the expres-
sion of most of these genes in fish, frog, and mouse embryos are suf-
ficient to promote the formation of retinal tissue (3, 14, 41–44). In 
contrast, null mutations in some of these same genes (e.g., Rax, Pax6, 
and Lhx2) arrest development at various key steps during eye forma-
tion (14, 15, 45). In addition, Vsx2 activity is known to be required 
for maintaining NR identity (20, 21), and Wnt/β-catenin signaling 
is required for RPE development (46, 47). Despite this knowledge, 
until now no information was available about the specific genes and 
mechanisms that guide NR specification.
In this article, we demonstrate that conditional inactivation of 
Six3 in the mouse anterior neural plate including the eye field is 
sufficient to arrest the specification of the NR but not that of the 
RPE. We showed that in Six3 conditional–mutant embryos, the 
initial step of eye field induction is not affected; however, later on, 
the specification of the NR is arrested, as revealed by the lack of 
expression of the presumptive NR markers Six6, Vax2, Tbx5, and 
Vsx2 in the mutant optic vesicles. We determined that the ectopic 
rostral expansion of Wnt8b expression as early as E8.5 is a key early 
response to Six3 functional inactivation. Thus, we conclude that 
the specification of the NR and RPE fates from their common eye 
field progenitors is under the control of distinct molecular pro-
grams and that Six3 is specifically required for NR specification.
Regionalization of the vertebrate forebrain requires the inhibi-
tion of posteriorizing Wnt signaling (24, 48), and we have previ-
ously shown that Six3 suppression of Wnt1 activity in the anterior 
neuroectoderm is essential for vertebrate telencephalic develop-
ment (24). Similarly, the antagonism of the Wnt/β-catenin pathway 
is also necessary during zebrafish eye field development because 
its activity suppresses eye field formation (27, 37). However, this 
work did not identify the mechanisms by which Wnt activity was 
specifically antagonized, nor was this activity directly linked to 
the process of NR specification. We have now identified Wnt8b as 
another direct target of Six3 and demonstrated that Six3 suppres-
sion of Wnt8b expression in the anterior neural plate is required 
during NR specification in mammalian embryos. Our data show-
ing that NR specification was specifically suppressed upon the 
ectopic anterior expansion of Wnt8b in Six3 conditional–mutant 
embryos or after forced expression of Wnt8b in transient trans-
genic embryos conclusively demonstrated that Wnt8b expression 
suppresses NR specification during the formation of the mam-
malian eye and that Six3 is the direct in vivo antagonist of this 
Wnt signaling activity during this process.
Currently, we do not know which other gene or genes involved in 
early eye development are affected by the conditional inactivation 
of Six3 or by the ectopic rostral expansion of Wnt8b. Among pub-
lished reports describing a series of key transcription factors that 
regulate early eye development, Six3 is the first gene to be described 
whose functional inactivation results in the arrest of neuroretinal 
specification in mammals. The fact that the described eye pheno-
types of Six6-, Vax2-, Fzd5-, or Tbx5-mutant embryos differ from 
that of Six3 mutants suggests that these genes probably do not 
contribute to the neuroretinal-specification phenotype observed 
in Six3 conditional–mutant embryos. However, it is reasonable to 
speculate that some of these genes indirectly contribute down-
stream of Six3 to regulate later aspects of retinal morphogenesis. 
In fact, we determined that normal Fzd5 expression is absent in 
the optic vesicles of E9.5 Fez:Wnt8b transgenic embryos (data not 
shown). This result suggests that Fzd5 is a direct target affected 
by the ectopic rostral expansion of Wnt8b activity, and its down-
regulation in Six3 conditional mutants could directly or indirectly 
affect the morphogenesis of the optic cups.
Interestingly, although the ectopic rostral expansion of Wnt8b 
was sufficient to suppress NR specification in Six3 conditional–
mutant embryos or in transient transgenic embryos, the specifica-
tion of the RPE was unaffected. This result suggests that the speci-
fication of these 2 cell types (NR and RPE) is under the control of 
distinct molecular programs and that Six3 is specifically required 
for the one leading to NR specification. Related to this idea, it 
was recently reported that Wnt/β-catenin signaling is essential for 
RPE specification (46, 47). Thus, although in zebrafish, canoni-
cal Wnt/β-catenin signaling antagonizes eye field specification and 
noncanonical Wnt signaling promotes early eye development (27), 
our work in mammals indicates that proper balancing of Wnt/ 
β-catenin signaling is essential to drive common eye field retinal 
progenitors to differentiate into either NR or RPE progenitors. In 
this case, Six3 activity is necessary to maintain a Wnt8b-free terri-
tory in the rostro-ventral margin of the anterior neural plate so 
that NR specification can normally occur.
Regionalization of the vertebrate forebrain requires that Wnt/
β-catenin signaling is gradually suppressed from the anterior 
neuroectoderm. Our work has now revealed that mammalian 
NR specification also requires a regulated balance of the activ-
ity of Wnt/β-catenin signaling in the developing eye field. We can 
conclude that Six3-mediated suppression of various members of 
the Wnt signaling pathway is a time-dependent, necessary step 
during the development of the mammalian forebrain and NR. 
Our results also suggest that fine tuning the timing of Six3 sup-
pression is essential in determining which Wnt family member 
will be antagonized and therefore in determining the telence-
phalic and NR fates in the anterior neural plate. Although telen-
cephalic formation requires Six3-mediated suppression of Wnt1 
at the 0- to 6-somite stage, NR specification requires Six3-medi-
ated suppression of Wnt8b a few hours later at the 6- to 8-somite 
stage. The knowledge gained from this study may help future 
efforts aimed toward controlling the differentiation of retinal 
cells in vivo and in vitro in embryonic stem cells or induced plu-
ripotent stem cells.
Methods
Mice. The Six3F/F and Six3+/Δ (25), Rx-Cre (26), BAT-gal (ref. 35; Jackson Labo-
ratories), and R26R (Jackson Laboratories) mouse strains were maintained 
in the NMRI background and genotyped as previously reported. To generate 
Fez-Wnt8b IRES YFP transgenic embryos, the Fez-Wnt8b IRES YFP cassette was 
excised from the plasmid by digestion with SalI; purified DNA was injected 
into mouse zygotes using standard protocols; and embryos were harvested 
at specific stages. Transgenic embryos were identified by YFP fluorescence 
under the dissecting stereomicroscope, and the genotype was confirmed by 
PCR for YFP. Animal experiments were approved by the Animal Care and Use 
Committee of St. Jude Children’s Research Hospital.
Plasmids. The plasmid Fez:Wnt8b IRES YFP for ectopic Wnt8b expression 
in the mouse forebrain was constructed by fusing a 2.8-kb section of the 
mouse Fezf2 promoter/regulatory element (39), a 1-kb cDNA fragment 
containing the entire mouse Wnt8b coding sequence generated by PCR 
from a Wnt8b cDNA plasmid (clone ID 40056929; Open Biosystems), and 
an IRES-Venus-SV40 polyA cassette.
The plasmid Fez:Six3 IRES YFP for ectopic Six3 expression in the mouse 
forebrain was constructed by replacing Wnt8b by the Six3 coding sequence 
in Fez:Wnt8b IRES YFP.
research article
3576	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 120   Number 10   October 2010
Immunohistochemistry and mRNA in situ hybridization. Standard protocols 
(25) were used. The following antibodies were used: anti-Six3 (1:400; pro-
vided by G. Oliver), anti-Rax (1:1000; Riken/CDB), anti-Sox2 (1:800; Chem-
icon), anti-Mitf (1:2,000; provided by H. Arnheiter, National Institute of 
Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA), 
anti-Pax6 (1:500; Covance), anti-Vsx2 (1:200; Abcam), anti-pH3 (1:2000; 
Upstate), anti-active caspase-3 (1:200, antigen retrieval, and TSA ampli-
fication; BD Biosciences). The following plasmids were used to generate 
probes for in situ hybridization: Six3 (XbaI/T7; provided by G. Oliver), Rax 
(HindIII/T7; provided by P. Mathers, West Virginia University School of 
Medicine, Morgantown, West Virginia, USA), Wnt8b (XbaI/T3; provided 
by B. Hogan, Duke University Medical Center, Durham, North Carolina, 
USA), Axin2 (NotI/T3; provided by F. Costantini, College of Physicians and 
Surgeons, Columbia University, New York, New York, USA), Wnt1 (EcoRI/
SP6; provided by M. Torres, Centro Nacional de Investigaciones Cardio-
vasculares, Madrid, Spain), Six6 (XbaI/T7; provided by X. Li, Children’s 
Hospital, Boston, Massachusetts, USA), Fzd5 (NotI/T7; IMAGE 445088), 
Fzd8 (NcoI/T3; Open Biosystems 40130820), Wnt11 (XhoI/T3; provided 
by A. McMahon, Harvard University, Cambridge, Massachusetts, USA), 
Vax2 (NcoI/T7; provided by C. Cepko, Harvard University, Boston, Mas-
sachusetts, USA), Tbx5 (SpeI/T7; provided by A. Joyner, Skirball Institute 
of Biomolecular Medicine, New York University School of Medicine, New 
York, New York, USA), Mitf (HindIII/T3; provided by H. Arnheiter), Sox2 
(XhoI/T3; provided by L. Robertson, Sir William Dunn School of Pathology, 
University of Oxford, Oxford, United Kingdom), Lhx2 (NotI/T7; provided 
by H. Westphal, National Institute of Child Health and Human Develop-
ment, NIH, Bethesda, Maryland, USA).
TUNEL and proliferation assays. Three 8- to 9-somite control and 3 con-
ditional Six3 mutant embryos were sectioned (coronal) through the optic 
vesicles region, and 6 sections of each were immunostained for pH3 and 
counterstained for DAPI. Their respective numbers were counted using 
Adobe Photoshop software. The percentage of pH3-positive cells was cal-
culated and the pH3 index was expressed as mean ± SD. Statistical signifi-
cance was analyzed by paired 2-tailed t test.
TUNEL assay was performed using ApopTag kit (Millipore) according to 
the manufacture’s instruction. At least 2 embryos from the control or the 
conditional Six3 mutant embryos were used.
DNA sequence comparison. Available DNA genomic sequences of mouse, 
human, chick, zebrafish, and fugu fish Wnt8b locus, including 5-kb upstream 
and 5-kb downstream sequences, were downloaded from the Ensembl data-
base and subjected to sequence comparison using the VISTA tool.
EMSA assay. The 2 DNA fragments for EMSA were amplified by PCR 
using the primers indicated in Supplemental Figure 4 and then subcloned 
into the T-easy vector (Promega) and sequenced for confirmation. These 2 
fragments were released from the plasmid by using NotI and labeled with 
[α -32P]dCTP using Klenow. Briefly, for EMSA, 1 μl of the labeled probes 
were incubated with 0.5 μl of purified GST or GST-Six3 protein in 15 μl of 
binding buffer (25 mM Hepes, pH 7.5; 100 mM KCl; 1 mM EDTA; 10 mM 
MgCl2; 0.1% NP-40; 5% glycerol; and 1 mM DTT) supplemented with 1 μl 
poly(dI-dC) (0.6 mg/ml) and 0.5 μl BSA (10 mg/ml) for 20 minutes at room 
temperature. Rabbit polyclonal antibody specific for Six3 (0.5 μl) or nor-
mal rabbit serum (0.5 μl) was added for another 20 minutes, and excess 
cold probe (400-fold more than hot probe) was added for competition. 
The DNA protein complex was resolved in 3.5% nondenaturing protein gel. 
Electrophoresis was done in ×0.5 TBE buffer at 150 V at room temperature 
for several hours. The gel was dried, and the protein-DNA complexes were 
visualized by autoradiography.
ChIP assay and qPCR. Chromatin isolated from the head (Six3 expressing) 
and trunk (Six3 negative) of E8.5 (8–15 somite stage) wild-type embryos 
was subjected to a ChIP assay with either Six3 antibody (our own) or nor-
mal IgG, and the precipitate was quantified by SYBR qPCR (Applied Bio-
systems). The enrichment was expressed as the value ratio between the Six3 
immunoprecipitated sample over the corresponding IgG immunoprecipitated 
sample. The detailed protocol is provided in Supplemental Methods.
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